352 related articles for article (PubMed ID: 30249439)
1. Percutaneous Left Atrial Appendage Closure With the Ultraseal Device: Insights From the Initial Multicenter Experience.
Asmarats L; Masson JB; Pagnotta PA; Cook S; Foresti M; Ibrahim R; Sukiennik A; Sabiniewicz R; Maffeo D; Carballo J; Cruz-González I; Grasso C; Pisano F; Senatore G; Tarantini G; Kasongo A; Chiarito M; Puricel S; Messas N; Moreno-Samos JC; O'Hara G; Rodés-Cabau J
JACC Cardiovasc Interv; 2018 Oct; 11(19):1932-1941. PubMed ID: 30249439
[TBL] [Abstract][Full Text] [Related]
2. Left atrial appendage closure: Initial experience with the ultraseal device.
Regueiro A; Bernier M; O'Hara G; O'Connor K; Paradis JM; Beaudoin J; Rodriguez-Gabella T; Champagne J; Rodés-Cabau J
Catheter Cardiovasc Interv; 2017 Nov; 90(5):817-823. PubMed ID: 27860249
[TBL] [Abstract][Full Text] [Related]
3. Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.
Ali M; Rigopoulos AG; Mammadov M; Torky A; Auer A; Matiakis M; Abate E; Bakogiannis C; Tzikas S; Bigalke B; Sedding D; Noutsias M
BMC Cardiovasc Disord; 2020 Feb; 20(1):78. PubMed ID: 32050904
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
[TBL] [Abstract][Full Text] [Related]
5. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
[TBL] [Abstract][Full Text] [Related]
6. Left atrial appendage closure with the II generation Ultraseal device: An international registry. The LIGATE study.
Pivato CA; Liccardo G; Sanz-Sanchez J; Pelloni E; Pujdak K; Xuareb RG; Cruz-Gonzalez I; Pisano F; Scotti A; Tarantini G; Cook S; Regazzoli D; Reimers B; Condorelli G; Bragato RM; Stefanini GG; Pagnotta P
Catheter Cardiovasc Interv; 2022 Oct; 100(4):620-627. PubMed ID: 35842775
[TBL] [Abstract][Full Text] [Related]
7. First Experience of Transcatheter Leak Occlusion With Detachable Coils Following Left Atrial Appendage Closure.
Della Rocca DG; Horton RP; Di Biase L; Bassiouny M; Al-Ahmad A; Mohanty S; Gasperetti A; Natale VN; Trivedi C; Gianni C; Burkhardt JD; Gallinghouse GJ; Hranitzky P; Sanchez JE; Natale A
JACC Cardiovasc Interv; 2020 Feb; 13(3):306-319. PubMed ID: 31954677
[TBL] [Abstract][Full Text] [Related]
8. Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug.
Saw J; Tzikas A; Shakir S; Gafoor S; Omran H; Nielsen-Kudsk JE; Kefer J; Aminian A; Berti S; Santoro G; Nietlispach F; Moschovitis A; Cruz-Gonzalez I; Stammen F; Tichelbäcker T; Freixa X; Ibrahim R; Schillinger W; Meier B; Sievert H; Gloekler S
JACC Cardiovasc Interv; 2017 Feb; 10(4):391-399. PubMed ID: 28231907
[TBL] [Abstract][Full Text] [Related]
9. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
11. Early Canadian Multicenter Experience With WATCHMAN for Percutaneous Left Atrial Appendage Closure.
Saw J; Fahmy P; Azzalini L; Marquis JF; Hibbert B; Morillo C; Carrizo A; Ibrahim R
J Cardiovasc Electrophysiol; 2017 Apr; 28(4):396-401. PubMed ID: 28128883
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of percutaneous left atrial appendage closure using a novel LAmbre occluder in patients with atrial fibrillation: Initial results from a prospective cohort registry study.
Chen S; Schmidt B; Bordignon S; Bologna F; Nagase T; Tsianakas N; Perrotta L; Chun KRJ
J Cardiovasc Electrophysiol; 2018 Feb; 29(2):291-297. PubMed ID: 29149516
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous left atrial appendage closure with the AMPLATZER cardiac plug device in patients with nonvalvular atrial fibrillation and contraindications to anticoagulation therapy.
Urena M; Rodés-Cabau J; Freixa X; Saw J; Webb JG; Freeman M; Horlick E; Osten M; Chan A; Marquis JF; Champagne J; Ibrahim R
J Am Coll Cardiol; 2013 Jul; 62(2):96-102. PubMed ID: 23665098
[TBL] [Abstract][Full Text] [Related]
14. Initial experience of percutaneous left atrial appendage closure using the LAmbre device for thromboembolic prevention.
Reinsch N; Ruprecht U; Buchholz J; Edel C; Kälsch H; Neven K
J Cardiovasc Med (Hagerstown); 2018 Sep; 19(9):491-496. PubMed ID: 29894355
[TBL] [Abstract][Full Text] [Related]
15. Intracardiac Echocardiography to Guide Watchman FLX Implantation: The ICE LAA Study.
Nielsen-Kudsk JE; Berti S; Caprioglio F; Ronco F; Arzamendi D; Betts T; Tondo C; Christen T; Allocco DJ
JACC Cardiovasc Interv; 2023 Mar; 16(6):643-651. PubMed ID: 36764917
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Left Atrial Appendage Closure With WATCHMAN in Japanese Nonvalvular Atrial Fibrillation Patients - Final 2-Year Follow-up Outcome Data From the SALUTE Trial.
Aonuma K; Yamasaki H; Nakamura M; Matsumoto T; Takayama M; Ando K; Hirao K; Goya M; Morino Y; Hayashida K; Kusano K; Gomi Y; Main ML; Uchida T; Saito S
Circ J; 2020 Jul; 84(8):1237-1243. PubMed ID: 32595176
[TBL] [Abstract][Full Text] [Related]
17. Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices.
Weise FK; Bordignon S; Perrotta L; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
EuroIntervention; 2018 Apr; 13(18):e2138-e2146. PubMed ID: 29400653
[TBL] [Abstract][Full Text] [Related]
18. Left atrial catheter ablation in patients with previously implanted left atrial appendage closure devices.
Wintgens LIS; Klaver MN; Swaans MJ; Alipour A; Balt JC; van Dijk VF; Rensing BJWM; Wijffels MCEF; Boersma LVA
Europace; 2019 Mar; 21(3):428-433. PubMed ID: 30380015
[TBL] [Abstract][Full Text] [Related]
19. Left atrial appendage closure: First in man with the 4th generation WATCHMAN device.
Ledwoch J; Franke J; Gonzaga M; Bertog S; Braut A; Hofmann I; Vaskelyte L; Gafoor S; Reddy V; Sievert H
Catheter Cardiovasc Interv; 2016 Mar; 87(4):787-94. PubMed ID: 26354821
[TBL] [Abstract][Full Text] [Related]
20. Device Thrombosis After Percutaneous Left Atrial Appendage Occlusion Is Related to Patient and Procedural Characteristics but Not to Duration of Postimplantation Dual Antiplatelet Therapy.
Pracon R; Bangalore S; Dzielinska Z; Konka M; Kepka C; Kruk M; Kaczmarska-Dyrda E; Petryka-Mazurkiewicz J; Bujak S; Solecki M; Pskit A; Dabrowska A; Sieradzki B; Plonski A; Ruzyllo W; Witkowski A; Demkow M
Circ Cardiovasc Interv; 2018 Mar; 11(3):e005997. PubMed ID: 29463510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
